Board Member Torsten Goesch Has Passed Away Suddenly

MARKN.

STOCKHOLM, SVERIGE - 5 september 2024: Modus Therapeutics Holding AB (”Modus Therapeutics”) announces today the sudden passing of board member Torsten Goesch.

Modus Therapeutics CEO John Öhd commented:” It is with great sadness that we at Modus Therapeutics announce the sudden passing of our board member Torsten Goesch. Torsten was a valued and respected member of our board, and he made significant contributions to the company's development during his time with us. He will be greatly missed. Our thoughts are now with his family and loved ones during this difficult time."

Modus Therapeutics’ nomination committee has initiated the process of appointing a successor for Torsten Goesch, and further information will be communicated shortly.

Datum 2024-09-05, kl 18:10
Källa MFN
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet